Erlotinib

Kinase Inhibitor

NADAC/unit N/A

No Shortage Tier 1: 55.6% PA Req: 290.9% 8 Manufacturers 23 ANDAs

Erlotinib targets specific kinase enzymes involved in cancer cell growth and proliferation.

Covered Lives

Generic Manufacturers

ALEMBIC PHARMACEUTICALS LTDCHARTWELL RX SCIENCES LLCHETERO LABS LTD UNIT VMSN LABORATORIES PRIVATE LTDRISING PHARMA HOLDINGS INCSHILPA MEDICARE LTDTEVA PHARMACEUTICALS USA INCZYDUS PHARMACEUTICALS USA INC

Explore in the Ecosystem

rxsaver.aiCompare prices for Erlotinib drfinder.aiFind doctors who prescribe Erlotinib rxpbm.aiPBM spread analysis for Erlotinib clinicalrx.aiClinical profile: Erlotinib

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.